Alterola Biotech, Inc. (ALTA) financial statements (2021 and earlier)

Company profile

Business Address 340 S. LEMON AVE., #4041
WALNUT, CA 91789
State of Incorp.
Fiscal Year End September 30
SIC 10 - Metal Mining (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments    3 9
Cash and cash equivalents    3 9
Receivables21     
Prepaid expense      13
Advance royalties  11   
Other undisclosed current assets 50    1
Total current assets:251113 23
Noncurrent Assets
Other undisclosed noncurrent assets    6 6
Total noncurrent assets:    6 6
Other undisclosed assets12  2 6 
TOTAL ASSETS:1551138629
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities180842111383524
Accrued liabilities 242111383524
Employee-related liabilities18060     
Debt  666630
Due to related parties    11 
Other undisclosed current liabilities372268249206170126
Total current liabilities:21786295267250212180
Noncurrent Liabilities
Long-term debt and lease obligation 2030 3030 
Long-term debt, excluding current maturities 2030 3030 
Total noncurrent liabilities: 2030 3030 
Total liabilities:217106325267280242180
Stockholders' equity
Stockholders' equity attributable to parent, including:(203)(56)(295)(264)(241)(205)(150)
Common stock117116115115115115115
Additional paid in capital652541170133133133133
Deferred compensation equity (36)     
Accumulated deficit(971)(713)(580)(512)(489)(453)(398)
Other undisclosed stockholders' equity attributable to parent 36     
Total stockholders' equity:(203)(56)(295)(264)(241)(205)(150)
Other undisclosed liabilities and equity    (30)(30) 
TOTAL LIABILITIES AND EQUITY:15513038629

Income statement (P&L) ($ in thousands)

9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
Gross profit:     (18)(3)
Operating expenses(258)(123)(49)(15)(20)(41)(59)
Other operating income (expense), net
(Other Expenses)
    (16)(14)13
Other undisclosed operating income (loss)    1632(11)
Operating loss:(258)(123)(49)(15)(20)(41)(59)
Nonoperating expense
(Other Nonoperating expense)
(0)(11)(19)(8)   
Interest and debt expense(0)(11)(19)(8)(16)(14)(10)
Loss from continuing operations before income taxes:(259)(144)(86)(30)(36)(55)(70)
Income tax expense(82)(45)     
Net loss:(341)(189)(86)(30)(36)(55)(70)
Other undisclosed net income (loss) attributable to parent8356    (3)
Net loss attributable to parent:(259)(133)(86)(30)(36)(55)(73)
Preferred stock dividends and other adjustments  (37)    
Other undisclosed net income available to common stockholders, basic  568   
Net loss available to common stockholders, diluted:(259)(133)(68)(23)(36)(55)(73)

Comprehensive Income ($ in thousands)

9/30/2019
9/30/2018
9/30/2017
9/30/2016
9/30/2015
9/30/2014
9/30/2013
Net loss:(341)(189)(86)(30)(36)(55)(70)
Comprehensive loss, net of tax, attributable to parent:(341)(189)(86)(30)(36)(55)(70)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: